Abstract. Transcription factor 7 like 2 (TCF7L2, also known as TCF4) is a Wnt signaling pathway transcription factor involved in regulation of numerous Wnt targeted genes. Recently, thousands of high-confidence TCF4 binding sites were reported in LS174T colon carcinoma cells, however, potential TCF4 target miRNAs remain largely unknown. Here, we utilized a bioinformatics approach to discover 26 miRNA transcription start sites (TSSs) within close proximity to TCF4 chromatin occupancy sites, and validated these sites as bona fide TCF4 targets in LS174T colon carcinoma cells, MCF-7 breast cancer cells and U87 glioma cells by ChIP-PCR. We then selected miR-21 to demonstrate for the first time direct TCF4 transcriptional activation of a miRNA via binding to the promoter region. Tissue array analysis supported this finding, revealing a positive correlation between activation of the β-catenin pathway and in situ expression of miR-21. Finally, based upon the well known but poorly understood preventive effect of aspirin on colorectal cancer incidence and mortality, we report downregulation of miR-21 upon administration of aspirin. In sum, our findings identify direct transcriptional regulation of miR-21 by TCF4 and suggest a role for miR-21 in cancer cell proliferation and invasion upon activation of β-catenin/TCF4 signaling.
Introduction
Transcription factor 7 like 2 (TCF7L2, also called and hereafter referred to as TCF4) is a 76-kDa protein encoded by a single exon. The N-terminal 53 amino acids of TCF4 bind with high affinity to β-catenin, forming the TCF/β-catenin transcription complex that regulates transcriptional responses to Wnt signaling (1) . Aberrant activation of Wnt signaling results in a transcriptional profile in human cancer cells similar to that found in cells physiologically driven by TCF/β-catenin, such as intestinal stem/progenitor cells (2) . Amongst the TCF/β-catenin regulated genes found overexpressed in cancers many are involved in survival pathways, including EGFR, STAT3, C-myc, and MMP2/9 (3, 4) . TCF4 chromatin occupancy appears to function both as a developmental transcription factor necessary for progenitor cell development and as the primary transforming factor in human tumors such as colorectal cancer.
miRNA have been implicated in the pathogenesis of several human diseases, such as neurodegenerative disorders, diabetes and more recently in viral and metabolic diseases (5, 6) . In recent years, miRNAs have been identified in the progression of various cancers and proposed as novel targets for anticancer therapies (7, 8) . Although miRNAs are key regulators of gene expression in both normal human physiology and disease, and thousands of microRNAs have been identified in organisms from viruses to primates through cloning and sequencing, or computational prediction based on strong conservation of miRNA sequence motifs, the transcriptional regulation of miRNA are poorly understood (9, 10) . In the present work, we perform a TCF4 binding localization analysis to identify miRNAs that have TCF4 bound at their proximal promoters. Our results detected 26 miRNAs that are high-confidence direct TCF4 targets. Further, we validated these findings by demonstrating that TCF4 influences miR-21 expression by direct binding to the promoter region. These experiments provide new insight into how TCF4 affects miRNA expression, and how these changes in miRNA expression may influence cancer progression.
Materials and methods

TCF4 peak analyses.
High-confidence TCF4-binding sites (n=6,868), previously identified by Hatzis et al (1) , were chosen for analysis. Binding site peaks located within 10 kb of transcription initiation sites were selected as likely to impact transcription regulation. for 10 min each. The ChIP incubation buffer were used to resuspended cells which were then sonicated at 5 W* for 12 pulses of 10 sec each using a VirSonic sonicator. The sonicated chromatin was centrifuged for 15 min and incubated for 12 h at 4˚C with either non-immune IgG (negative control), Tcf-4 (Millipore, 05-511), and Anti-RNA Polymerase II (positive control) at 1 µg of antibody per 10 6 cells with protein G beads. The beads were successively washed 2 times with low salt wash buffer 1, one time with high salt wash buffer 2, and one time with LiCi wash buffer 3 and two times with Tris-EDTA buffer 4 for 5 min each at 4˚C. The immune chromatin complexes were eluted by incubation of the beads with elution buffer at room temperature for 20 min, de-cross-linked by incubation at 65˚C for 5 h in the presence of 200 mM NaCl, extracted with phenol-chloroform, and precipitated. Purified DNA was subjected to PCR, and all sequences of the PCR primers used can be found in Table I . Two primers were chosen for each gene, in order to perform a perfect PCR, which needs to enhance specificity, primers were designed using the oligo 6 software.
Immunohistochemistry analysis. A colon cancer tissue microarray containing 120 patient samples was purchased from Chao Ying, Shanxi, China. β-catenin and TCF4 were stained with mouse anti-β-catenin and anti-TCF4 antibodies (Abcam 1:200 dilution), respectively, and detected following incubation with tetramethyl rhodamine isothiocyanate-conjugated goat secondary anti-mouse immunoglobulin G (IgG; Sigma 1:100 dilution). Sections were then incubated with ABC-peroxidase and DAB (diaminobenzidine), counterstained with hematoxylin, and visualized using light microscope (Olympus). samples was performed with in situ hybridization kit (Boster, Wuhan, China). LNA/DNA oligos contained locked nucleic acids at eight consecutive centrally located bases (indicated by the underline) and had the following sequences: LNA-miR-21 5'-TCAACATCAGTCTGATAAGCTA-3'. The in situ hybridization detection of miR-21 in tissue microarray was conducted according to the protocol of the manufacturer.
TOP-FOP reporter assay.
To detect the β-catenin/Tcf-4 activity, we used a pair of luciferase reporter constructs, TOP-FLASH and FOP-FLASH (Upstate). TOP-FLASH (with three repeats of the Tcf-binding site) or FOP-FLASH (with three repeats of a mutated Tcf-binding site) plasmids were transfected into LS174T colon cancer cells which was treated with aspirin. Luciferase activity was measured by the Dual-luciferase reporter assay system, with the Renilla luciferase activity as an internal control, 48 h after transfection.
Luciferase assays. Cells were cultured in 96-well plates in the presence of medium (DMEM supplemented with 10% fetal calf serum), or medium supplemented with 10 mM aspirin. Cells were transfected with pGL3-miR21-promoter or pGL3-basic vector reporter. Following 48-h incubation, luciferase activity was measured using a dual-luciferase reporter system (Promega).
Quantitative PCR (qPCR).
Four hours following incubation with 10 mM aspirin, total RNA was isolated from LS174T cells by the TRizol method. Reverse transcription was performed using a reverse transcription kit (Qiagen), and qPCR was used to detect the changes in miR-21 expression. U6 expression was utilized as a control. The primers were synthesized by Gene Pharma, Shanghai, China.
Western blot analysis. Parental and transfected cells were washed three times with pre-chilled phosphate-buffered saline (PBS). Separated proteins were transferred to PVDF membranes (Millipore, Bedford, MA, USA), and incubated with primary antibodies against PTEN, RECK and EGFR (Santa Cruz), followed by detection with an HRP-conjugated secondary antibody (Zymed). The membrane was stripped and re-probed with a primary antibody against GAPDH (Santa Cruz). 
Results
Identification of putative TCF4 peaks within 10 kb of miRNA genes.
To globally identify all direct TCF4-targeted genes, ChIP analysis was performed on LS174T colorectal carcinoma cells. Based on the median mean signal and the median variance of the dedicated array, 6,868 TCF4 peaks were observed (1). The hg17 Genome Browser was previously used to identify coordinate positions of the 6,868 peaks (1). Here, we utilized the hg19 Genome Browser to annotate gene positions. TCF4 binding regions within 10 kb of transcription initiation sites were considered likely to impact transcription regulation, and were selected for further analysis. Our findings identified 1793 peaks distributed within 10 kb of coding genes, and an additional 45 peaks in within 10 kb of miRNA coding regions (Fig. 1) . Next, we analyzed the selected TCF4 binding peaks for expression of the A-C/G-A/T-T-C-A-A-A-G TCF4 binding motif. After extraction of ~-500 to +500 bp from each peak position, we used patmatch (ftp://ftp.arabidopsis.org/ home/tair/Software/Patmatch/) to predict putative A-C/G-A/T-T-C-A-A-A-G motifs, with allowances for two mismatches. Our results indicate that every identified TCF4 peak contained this motif on the basis of mismatch requirements. These findings support the hypothesis that the identified TCF4 peaks represent specific DNA sequence bound with TCF4.
Stepwise differential expression rank analysis identified a significant correlation between TCF4 occupancy of target-gene regulatory regions and gene transcription (Fig. 2) . To determine whether TCF4 can regulate miRNA expression, we analyzed the association between peak location and human annotated miRNA-encoding genes.
TCF4-binding regions are distributed in clusters surrounding putative target genes. Hatzis et al demonstrated that TCF4 associated with as many as 11 peaks within 100 kb of the TSS of AXIN2, a well-known target gene of the Wnt pathway. Analysis of the 1793 peaks associated with protein-coding genes identified a considerable portion of genes associated with two or more TCF4 peaks. In fact, 132 genes displayed 2 TCF4 binding sites, 20 genes displayed 3 TCF4 peaks, and 5 genes displayed 4 TCF4 peaks. Based upon these data, we identified 1606 protein-coding genes within 10 kb distance of TCF4 peaks. Interestingly, many TCF4 binding sites are distributed in close proximity to miRNA transcription initiation sites. Analysis identified 45 putative peaks that potentially influenced the expression of 38 distinct miRNA (5 miRNA were clustered by 2 TCF4 peaks, and hsa-miR-2110 was clustered by 3 peaks). These data suggest that TCF4 may signal via transcriptional regulation of both coding and non-coding (such as miRNAs) genes.
TCF4 binds to the putative sites in the promoter element of 26 distinct miRNA. Through TCF4 tiling array analysis, we obtained TSSs of 38 miRNA found within 10 kb of TCF4 binding sites. Our calculations, however, included both upstream and downstream ranges of TCF4 occupancy. As TCF4 can potentially regulate miRNA expression by binding with their promoters upstream of an open reading frame (OPR), we selected 26 miRNAs whose transcription initiation sites are located downstream of TCF4 bound regions (28 peaks, including has-miR-2110 and hsa-miR-1252 that each contained 2 upstream TCF4 binding sites within 10 kb). Each miRNA was validated by conventional ChIP. To determine whether the TCF4 binding sites associated with these 26 miRNAs are enriched in TCF4-bound promoter regions, we performed ChIP-PCR in U87, LS174T and MCF-7 cells. Primers were designed specifically around each peak, and enrichment was performed using Oligo 6 software (described in Table I ). Despite inconsistency in miRNA expression among U87, LS174T and MCF-7 cells, our data strongly suggest that TCF4 interacts with the promoter regions of miRNA. Further, immunodetection identified fivefold increase in TCF4 expression compared to negative controls (Fig. 3) . These data are highly provocative, as many of the miRNA identified, including miR-21, miR-10a, miR-23b and miR-566, are found to be overexpressed in many human cancers (11-21).
TCF4 activates miR-21 transcription by directly binding to its promoter. Tiling array analysis and ChIP-PCR identified miR-21
as a candidate TCF4 transcriptional target. MiR-21 expression is significantly enhanced in a variety of solid tumors, including glioblastoma, breast, lung, colon, prostate, pancreas, and stomach cancers (16) (17) (18) (19) (20) (21) . Further, differential expression of miR-21 was observed in colon cancer, based upon tumor status, TNM staging, survival prognosis, and response to adjuvant chemotherapy (22) . Although our results identify 9 miRNA regulated by TCF4, colon cancer tissue microarray containing 120 patient samples revealed that the only miRNA with differential expression in tumor vs. adjacent normal tissue was miR-21 (Table II) 
Discussion
Wnt/β-catenin/TCF signaling pathway has been shown to be a crucial factor in the development of many cancers. This complex regulates transcription of multiple genes involved in cellular proliferation, differentiation, survival and apoptosis, including Fra-1, c-myc and Cyclin D. In the past, our group has demonstrated that Wnt/β-catenin/TCF signaling was significantly dysregulated in gliomas and down-regulated β-catenin/ TCF signaling which can inhibit cell proliferation and invasive ability, induced apoptotic cell death (23) . Furthermore, we clarified that down-regulation of β-catenin/TCF signaling inhibited several members of the EGFR pathway in human glioma cells (24) . Association of deregulated Wnt/β-catenin/TCF signaling for cancer treatment has thus generated significant interests. Accordingly, many documents suggest that β-catenin and TCF-4 play an important role in epithelial cancer progression and prognosis or prediction of response to therapy (25) (26) (27) report which published in the Lancet elaborated daily aspirin reduced deaths of colon carcinoma during and after the trials supplied the patient evidence (28) . miRNA regulate gene expression by promoting or inhibiting the recruitment of RNA polymerase (28, 29) , but the regulation of miRNAs in transcript was still unknown. The goal of the current study was to investigate whether the transcription factor TCF4 binds the promoter region of miRNA, regulating miRNA expression. Analysis of 6,868 TCF4 binding peaks previously identified using the genome wide ChIP-on-chip approach revealed that 1,793 biding sites were found in unique genes encoding protein, while 45 peaks were potentially found in the promoter region of miRNA. To demonstrate TCF4 interaction with a miRNA promoter, we employed ChIP-PCR to detect 26 miRNAs occupied downstream of TCF4 among U87, LS174T and MCF-7 cells. Mir-21 as one of the commonly implicated miRNAs in cancers is highly up-regulated and causally linked to proliferation, apoptosis, and migration of various cancer cell lines. Reporter assay confirmed a direct role for TCF4 in the regulation of miR-21 expression in LS174T colon carcinoma cells. Finally, we determined by tissue microarray that TCF4-driven miR-21 expression increased with colon cancer stage.
In conclusion, this study demonstrated that the transcription factor TCF4 can bind to the promoters of miRNAs and profoundly alter their expression. In past work, we demonstrated a role for miRNA in tumorigenesis, via binding to the seed sequence at the 3'-UTR (untranslated region) of target mRNAs and influencing the activity of the Wnt signaling pathway (20, 21, 30, 31) . The present study for the first time provides evidence that the β-catenin/TCF signaling pathway can regulate numerous miRNAs transcription, and discovers the reason for miR-21 high expression in epithelial cancer. Collectively, these studies indicate that further investigation of the miRNA regulated by TCF4, and the potential impact of TCF4 gene silencing on both miRNA expression and tumorigenesis, are clearly warranted.
